Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation | Journal of Molecular Medicine Gwyer D, et al
The peptide operates through several identified mechanisms including upregulation of growth hormone receptors, activation of the FAK-paxillin pathway essential for cell migration, promotion of angiogenesis through VEGF modulation, and interaction with the nitric oxide system
For CJC-1295 with DAC, timing is less critical due to the extended half-life, though many researchers prefer evening administration
"BPC" stands for "Body Protection Compound." In preclinical work it is proposed to act through several overlapping pathways, including promotion of new blood-vessel growth (angiogenesis), modulation of nitric-oxide signaling, and anti-inflammatory activity, rather than through one well-defined receptor mechanism the way a conventional small-molecule drug does
This is Peptide Nutrition 101 Apr 28, 2026 Your Protocol Is Dialed In